Dova Pharmaceuticals

Dova Pharmaceuticals is a pharmaceutical company focused on developing treatments for thrombocytopenia. The company's lead product, avatrombopag, has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver disease.